Biotechnology innovation is no longer confined to labs run by universities, governments, or large pharmaceutical companies. Today, a growing number of biotech patents are being put forth by startups and other small independent research teams that do not own any laboratories of their own. Indeed, unlike in earlier waves of research democratisation, they aren’t renting labs on long-term leases either. More than ever, these teams are choosing BSL-2 lab rental arrangements as needed, not just to preserve capital but also to demonstrate good business sense to potential investors.
This new way of doing things is currently driving progress in areas as diverse as therapeutics, diagnostics, agritech, and synthetic biology. In the Asia-Pacific region, Singapore has emerged as one of the region’s most active biotech hubs, supported by a decades-long state-directed effort to provide strong domestic research institutions and a growing, international pool of scientific talent.
However, transforming a scientific concept into a viable product requires more than just having the needed technical expertise in one place. Biotech research for commercial purposes requires economical access to specialised laboratory infrastructure that meets strict biosafety and regulatory standards. With the advent of rentable BSL-2 labs, it’s finally possible for more biotech innovators to access the facilities they need without the enormous barriers that used to almost define biotechnology research.
Let’s get into why these rentable facilities have become so important, not just for small biotech teams, but even for established biotechnology firms that may already have facilities of their own.
Why Lab Infrastructure Is a Major Barrier for Biotech Startups
Developing commercially viable biotech products almost always requires access to a laboratory that passes the intended market’s regulatory compliance standards. To start, biosafety-rated lab environments must meet strict requirements for ventilation, waste handling, access control, and monitoring. These standards are essential for safely handling biological materials. As a general rule, these standards have only gone up with time, making them progressively difficult to meet.
As one might imagine, building such a facility requires significant upfront investment. Equipment such as biosafety cabinets, incubators, centrifuges, and cold storage systems can cost hundreds of thousands of dollars before any samples are stored. Additional expenses will almost certainly arise from facility design, safety systems, and various regulatory compliance processes. Note that these areas will consume capital potentially years before the startup can produce its first patent, let alone its first commercially-viable offering.
For early-stage startups testing pilots or proof-of-concept ideas, these costs can be extremely difficult to surmount. Founders may spend months securing space, installing equipment, and setting up safety protocols before they can even begin experiments. Having fully-equipped, compliant biosafety labs readily available allows research and business goals to be met at launch, with minimal delays, allowing founders to quickly meet research goals and present more compelling cases to investors.
What Shared Biosafety Labs Provide
At well-regarded research hubs like Singapore’s Biopolis, shared biosafety laboratories are professionally managed environments, designed from the ground up to be used by multiple organisations with different needs and commitment levels. They typically include:
- Flexible Usage Contracts. Startups can access fully equipped facilities on a flexible basis and ramp up or bring down their commitments as their research requires. This avoids the need to overpay on long leases and can provide organizations with an easy way to build up their capacity as their needs expand.
- Infrastructure for “Wet” and Biohazardous Matter. Most shared labs include standard wet lab infrastructure such as biosafety cabinets, fume hoods, autoclaves, incubators, and centrifuges. Those dealing with biohazardous materials may also have temperature-controlled storage, specialised workstations, and secure sample handling systems.
- Administrative Support. In addition to equipment, these facilities often provide operational support. In general, safety procedures, equipment maintenance, and compliance monitoring are managed by the facility operator. In practice, this allows research teams to focus on scientific work rather than facility management, avoiding the need for learning on the job or extra hires.
How These Labs Support Collaboration in Singapore’s Biotech Ecosystem
Shared laboratory environments are also proven idea incubators, encouraging connection and collaboration between researchers working on different projects. It’s important to remember that it’s not just startups that use these facilities. Indeed, established biotech conglomerates regularly use these rented facilities as a cost-effective way to run exploratory research without committing resources to permanent lab expansion.
When multiple research teams operate in the same facility, opportunities for knowledge exchange increase naturally, as they would in a high-level university setting. Singapore’s biotech ecosystem already benefits from strong, meticulously-planned links between universities, research institutes, and industry, with these labs forming the nuclei of a vital knowledge network that’s practically impossible to create in isolation. Such environments often lead to “eureka moments” in informal discussions and, quite often, potential research partnerships.
Rented BSL-2 Labs: The Silent Engine Behind Singapore’s Biotech Innovation
While biotech breakthroughs often attract headlines, the infrastructure supporting them receives far less attention. Yet, it’s through shared biosafety laboratories that today’s scientists and startups are able to move from concept to product in years rather than decades. For startups and companies working on biotech in Singapore, these facilities are now truly an essential part of the innovation pipeline.
